Howard Margolese
Associate Professor
Psychiatry
McGill University
Canada
Biography
Dr. Margolese is an Associate Professor in the Department of Psychiatry at McGill University. He is currently the Program Director of the McGill RCPSC Clinical Pharmacology residency program. He is also the Associate Medical Firector of the MUHC Early Psychosis and Schizophrenia Spectrum Program (EPSSP) and director of the Clinical Psychopharmacology Unit’s consultation service. Dr. Margolese enjoys teaching both residents and medical students and is the coordinator of the continuing care rotation for residents at the MUHC. Dr. Margolese’s research interests include drug-induced movement disorders, substance abuse in schizophrenia (dual diagnosis), pharmacotherapy of schizophrenia, and adverse effects of psychotropic medications. He is either a PI or co-investigator for several clinical research trials. He has given numerous lectures and presentations both nationally and internationally and published over 50 articles and letters to the editor, as well as several book chapters. He is a peer reviewer for several leading psychiatric journals. In his clinical work, Dr. Margolese specializes in the psychopharmacology consultation of treatment resistance or complex psychopharmacology regimens, first episode psychosis, and chronic and treatment-resistant schizophrenia.
Research Interest
clinical pharmacology
Publications
-
Aripiprazole-Induced Hypoprolactinemia in an Adult Male with First-Episode Psychosis. Propst AJ, Jarvis GE, Margolese HC.
-
Generic formulations of psychotropic medications and treatment response. Bhat V, Margolese HC.
-
Comparing three-year extension of early intervention service to regular care following two years of early intervention service in first-episode psychosis: a randomized single blind clinical trial. Malla A, Joober R, Iyer S, Norman R, Schmitz N, Brown T, Lutgens D, Jarvis E, Margolese HC, Casacalenda N, Abdel-Baki A, Latimer E, Mustafa S, Abadi S.
